Researchers at Stanford have developed a biodegradable device and platform carrier of biologics for promoting faster bone healing of large bone defects, fractures, and non-union.
Stanford inventors have developed an early-stage screening method to diagnose abdominal aortic aneurysms (AAA). AAA is a common cardiovascular disease with high prevalence in European men 65 years and above.
Stanford researchers have developed a new method of imaging cholesteatoma, an expanding and destructive lesion of the middle ear and mastoid, based on its chemical composition.
Stanford scientists have invented a new PET-nanophotonic metamaterial scintillator that consists of tunable scintillating alkaline-earth rare-earth fluoride nanoparticles (MLnF) for low-dose, high-resolution PET imaging.
Researchers at Stanford have developed an innovation that will enhance the depth of the imaging capabilities for optical coherence tomography (OCT) imaging.
Researchers at Stanford have developed a biodegradable device and platform carrier of biologics for promoting faster bone healing of large bone defects, fractures, and non-union.
Knee osteoarthritis is the most common cause of musculoskeletal pain in adults, leading to limited mobility and various health issues. This breakthrough technology developed by Stanford researchers offers a promising solution.
Stanford researchers at the Snyder Lab have developed a novel software application, called the Metabolic Subphenotype Predictor, which predicts if a patient is insulin resistant through continuous glucose monitoring.
Stanford researchers have designed a remote digital health platform to assist diagnosis and management of some inflammatory skin conditions, such as eczema.
Stanford researchers at the Lee Lab have developed a new system and method for measuring pathology then applying a novel algorithm to optimize neurostimulation therapy for altering pathology for treatment of neurodegenerative diseases.
Stanford researchers at the Lee Lab have developed a method to understand whole-brain circuit mechanisms underlying neurological disease and its application to predict the outcome of therapeutic interventions.
Stanford researchers have developed novel designs for 3D-printed microarray patches (MAPs) that can improve intradermal drug delivery and sampling. These designs support the use of microneedles for minimally invasive therapy administration and diagnostics.
Stanford researchers have developed a patient classification method (healthy, idiopathic, diabetic, etc.) based on a quantitative assessment score derived from autonomic and gastric electrocardiogram (ECG) and electrogastrogram (EGG) data.